Beckman Coulter's acquisition of Clinical Data's Cogenics division, announced last week, will add more services, a wider geographic reach, and a CLIA-certified lab to its Agencourt Biosciences business.

Up until now, Agencourt has been focusing primarily on DNA sequencing services and nucleic acid purification products. The company, based in Beverly, Mass., is equipped with more than 30 ABI 3730xl sequencers, two Roche/454 GS FLX instruments, two Applied Biosystems SOLiD 3 instruments, and a recently purchased Illumina Genome Analyzer II.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.